))
4: Mike Zack, PGxAI
Manage episode 446789490 series 3585315
Content provided by Venture Vitals by Caelestinus. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venture Vitals by Caelestinus or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In their fourth epizode, Venture Vitals’ Tomas Studenik and Evgeny Shvarov invited a precision medicine startup CEO, Mike, to be their guest and respondent for over 45 minutes of all-about-building-a-global-med-tech-unicorn. Mike Zack, MD, PhD, MPH, is the Co-Founder and CEO of PGxAI (https://pgx.ai), a key opinion leader (KOL) in pharmacogenomics with an H-index of 40 and >40K citations. Mike is a member of major pharmacogenomics consortiums, including CPIC and PGRN, and has published in top-tier journals such as Nature Pharmacogenomics Journal, The Lancet, and others. Mike is supported by his co-founder and investor Allan Gobbs, who has successfully exited nine companies, and Russ Altman, a Stanford professor, serial entrepreneur, and world-leading KOL in multi-omics.
PGX.ai is a Caelestinus Health Tech Incubator alumnus.
PGX.ai is a Caelestinus Health Tech Incubator alumnus.
7 episodes
Share
